Market entry · Yemen

Entering the Yemen market: a manufacturer's guide to distribution

For an international manufacturer of pharmaceuticals, medical devices or laboratory equipment, Yemen is a market defined by real, structural demand. Reaching it well takes local knowledge and the right partner. This guide sets out what the numbers say about the need, the barriers to entry, and how to build a channel that works.

The scale of need

Yemen is a country of roughly 40.6 million people (World Bank, 2024).¹ It is also the site of one of the world's largest humanitarian situations: the UN estimates that more than 22 million people — around half the population — require humanitarian assistance and protection in 2026.²

Health need is central to this. The health system has been severely strained: as of the 2026 humanitarian planning cycle, only 59.3% of health facilities are fully functional, meaning just over 40% are only partially functional or not functioning at all.² The direction of travel matters: capacity is recovering, but demand for reliable medical supply remains enormous.

Why imports — and importers — matter

Yemen's domestic manufacturing meets only a fraction of demand. A peer-reviewed study, citing the national regulator's annual report, found the country imports roughly 80–90% of its medicines, with local production covering only about 10–20% of the market.³

For a manufacturer, the implication is direct: the market is reached through import and distribution, not local production. That makes your choice of in-country partner the single most important decision in your entry plan.

Registration comes first

Products generally must be registered before they can be distributed. Registration in Yemen runs through the Ministry of Public Health and Population and the Ministry of Industry and Trade. Medical devices are classified on an EU-style risk model, and an in-country authorised representative is typically required. Registration is document-heavy and specific to the product category; a local partner who has completed it before shortens the path and helps you avoid resubmissions.

Customs and import logistics

Getting goods into the country is its own discipline: import documentation, clearance and inland movement. Delays here are costly — especially for temperature-sensitive stock. Plan for it, and work with a partner who handles it routinely.

Cold chain is not optional

If any of your products are temperature-sensitive — vaccines, biologics, many reagents — an unbroken cold chain is essential. Most freeze-sensitive vaccines must be kept between 2°C and 8°C,⁵ and potency lost to a temperature excursion is cumulative and is not recovered by returning the product to the correct range.⁷ The evidence shows excursions are common: a systematic review found that between 14% and 35% of refrigerators or shipments exposed vaccines to freezing.⁶ Confirm your distributor maintains refrigerated transport, temperature monitoring and correct storage from port to end user.

Why a local partner usually wins

You could try to manage registration, customs, storage and sales from abroad — but each is a specialised, local task, in a demanding environment. A distributor who already holds the licences, the warehousing, the regulatory relationships and the customer base turns years of groundwork into a working channel from day one.

In summary

Yemen combines large, structural health demand with heavy import dependence and a challenging operating environment. Enter it with clear eyes on four things — registration, customs, cold chain and in-country reach — and choose a partner who covers all four.